CA Koller
Impact in
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
Papers in
-
- Biochemical and Molecular Research 4
- Cancer therapeutics and mechanisms 3
- Genetics 6
- Chronic Lymphocytic Leukemia Research 6
- Co-authors
- KA Foon (2 shared papers)DL Longo (2 shared papers)RG Steis (2 shared papers)Razelle Kurzrock (3 shared papers)Raymond Alexanian (2 shared papers)MJ Keating (2 shared papers)HM Kantarjian (2 shared papers)AF LoBuglio (2 shared papers)
- Journals
- Blood (12 papers)PubMed (1 paper)Proceedings of the American Association for Cancer Research (1 paper)
- Partner nations
- United StatesRussia
In The Last Decade
CA Koller
14 papers receiving 499 citations
Peers
Comparison fields: 5 of 57
- Genetics 183
- Hematology 180
- Physiology 53
- Pathology and Forensic Medicine 105
- Oncology 134
Countries citing papers authored by CA Koller
This map shows the geographic impact of CA Koller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by CA Koller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites CA Koller more than expected).
Fields of papers citing papers by CA Koller
This network shows the impact of papers produced by CA Koller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by CA Koller. The network helps show where CA Koller may publish in the future.
Co-authors
The 25 scholars most cited alongside CA Koller, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1986 | 153 | |
| 2 | 1992 | 126 | |
| 3 | 1990 | 80 | |
| 4 | 1980 | 71 | |
| 5 | 1980 | 51 | |
| 6 | 1981 | 29 | |
| 7 | 1983 | 17 | |
| 8 | 1992 | 5 | |
| 9 | 2'-Deoxycoformycin toxicity correlates with red cell dATP/ATP ratios | 1981 | 3 |
| 10 | 2-Chlorodeoxyadenosine: A new anticancer agent in lymphoid malignancies | 1991 | 3 |
| 11 | Role of glycolysis in deoxyadenosine induced ATP depletion and dATP accumulation in red cells. | 1984 | 3 |
| 12 | 1990 | 2 | |
| 13 | 1983 | 1 | |
| 14 | 1981 | 1 | |
| 15 | 1986 | 1 | |
| 16 | Erythrocyte adenosine triphosphate and deoxyadenosine triphosphate measurements predict toxicity following 2'- deoxycoformycin therapy | 1984 | 1 |
About CA Koller
CA Koller is a scholar working on Molecular Biology, Genetics, Public Health, Environmental and Occupational Health, Physiology and Epidemiology, having authored 16 papers that have together received 547 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (6 papers), Acute Lymphoblastic Leukemia research (5 papers), Erythrocyte Function and Pathophysiology (4 papers), Biochemical and Molecular Research (4 papers), Adenosine and Purinergic Signaling (3 papers), Cancer therapeutics and mechanisms (3 papers), Cytomegalovirus and herpesvirus research (3 papers) and Acute Myeloid Leukemia Research (2 papers). The work is most often cited by research in Genetics (183 citations), Hematology (180 citations), Physiology (53 citations), Pathology and Forensic Medicine (105 citations) and Oncology (134 citations). CA Koller has collaborated with scholars based in United States and Russia. Frequent co-authors include KA Foon, DL Longo, RG Steis, Razelle Kurzrock, Raymond Alexanian, MJ Keating, HM Kantarjian, AF LoBuglio, Hagop M. Kantarjian and Elihu H. Estey. Their work appears in journals such as Blood, PubMed and Proceedings of the American Association for Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.